Burkitt lymphoma in the mouse

Journal of Experimental Medicine

Volumn 192, Issue 8, 2000, Pages 1183-1190

  Kovalchuk, Alexander L ^a   Qi, Chen Feng ^b   Torrey, Ted A ^b   Taddesse Heath, Lekidelu ^b   Feigenbaum, Lionel ^c   Park, Sung Sup ^a   Gerbitz, Armin ^d   Klobeck, Gustav ^e   Hoertnagel, Konstanze ^d   Polack, Axel ^d   Bornkamm, Georg W ^d   Janz, Siegfried ^a   Morse III, Herbert C ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Institut f r Klinische Molekularbiologie und Tumorgenetik   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

Burkitt lymphoma; Locus control region; Mouse lymphoma; MYC; Translocation

Indexed keywords

CD23 ANTIGEN; CD5 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CANCER INFILTRATION; CELL SUBPOPULATION; CHROMOSOME TRANSLOCATION; GENE EXPRESSION; GENE LOCUS; MOUSE; NONHUMAN; PATHOGENESIS; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTO ONCOGENE; TRANSGENIC MOUSE;

ANIMALS; BURKITT LYMPHOMA; DISEASE MODELS, ANIMAL; EXONS; GENES, MYC; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-MYC; SPLEEN;

EID: 0034675943     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.192.8.1183     Document Type: Article

References (30)

1. A sarcoma involving the jaws in African children
2. Pathogenesis of small noncleaved cell lymphomas (Burkitt's lymphoma)
3. Marker band in one chromosome 14 from Burkitt lymphomas
4. Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells
5. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and mouse plasmacytoma cells
6. Breakpoints of Burkitt's lymphoma t(8;22) translocations map within a distance of 300 kb downstream of MYC
7. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting, Aidie House, Virginia, November, 1997
8. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
9. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma
10. The role of immunoglobulin κ elements in c-myc activation
11. c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1
12. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: Implications for the c-myc P1/P2 promoter shift
13. Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma
14. Locus control regions: Coming of age at a decade plus
15. Resolution and characterization of pro B and pre-pro B cell stages in normal mouse bone marrow
16. Transitional B cells are the target of negative selection in the B cell compartment
17. Positive selection of natural autoreactive B cells
18. Insight into Burkitt's lymphoma from immunoglobulin variable region gene analysis
19. The β-globin locus control region enhances transcription of but does not confer position-independent expression onto the lacZ gene in transgenic mice
20. Cutting edge: Ig heavy chain 3' HS1-4 directs correct spatial position-independent expression of a linked transgene to B lineage cells
21. Rapid induction of B-cell lymphomas in mice carrying a human IgH/c-myc YAC
22. The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice
23. Differences in the molecular structure of c-myc-activating recombinations in murine plasmacytomas and precursor cells
24. IgM receptor-mediated transactivation of the IgH 3' enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function
25. T cell controlled molecular pathway regulating the IgH locus: CD40-mediated activation of the IgH 3' enhancer
26. Post-translational regulation of E2A proteins via lipopolysaccharide and CD40 signaling
27. c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover
28. Plasmacytomagenesis in mice: Model of neoplastic development dependent on chromosomal translocations
29. Inhibition of plasmacytoma development in BALB/c mice by indomethacin